Home/ Stocks/ NVO

Novo-Nordisk A/S

NVO XNYS

$46.81 +0.95 (+2.08%) ▲ 15-min delayed

Open

$46.80

High

$47.10

Low

$46.63

Volume

2.43M

Market Cap

$191.24B

About Novo-Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Employees: 69.5K Website →

TickerDaily Coverage

Why Are These Stocks Making the Biggest Pre-Market Moves Today? June 18, 2026

Market News Sarah Mitchell · 5d ago

Five major stocks are making significant pre-market moves on June 18, 2026, driven by earnings...

Pre-Market Stock Movers Today: Top 5 Stocks Moving Big Before the Bell (June 10, 2026)

Market News Sarah Mitchell · Jun 10, 2026

Five major stocks are moving sharply in pre-market trading on Wednesday, June 10, 2026, ahead of...

Why Are These Stocks Moving Big Pre-Market Today? Top 5 Movers for June 4, 2026

Market News Sarah Mitchell · Jun 4, 2026

Five major stocks are making outsized moves in pre-market trading on Thursday, June 4, 2026, driven...

Top Stocks Moving Pre-Market Today: NVDA, LLY, AMD Pre-Market Movers Before the Bell

Market News Sarah Mitchell · Mar 6, 2026

Several major stocks are posting outsized pre-market moves ahead of today's opening bell, driven by...

Why Is Allurion Technologies (ALUR) Stock Up 67.4% Today?

Penny Stocks Marcus Rivera · Feb 23, 2026

Allurion Technologies (ALUR) stock exploded 67.4% to $1.7901 on massive 125.3M-share...

View All Coverage →

Get NVO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Novo-Nordisk A/S.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.